Incyte

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Incyte and other ETFs, options, and stocks.

About INCY

Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas. 

CEO
William J. Meury
CEOWilliam J. Meury
Employees
2,844
Employees2,844
Headquarters
Wilmington, Delaware
HeadquartersWilmington, Delaware
Founded
1991
Founded1991
Employees
2,844
Employees2,844

INCY Key Statistics

Market cap
22.95B
Market cap22.95B
Price-Earnings ratio
16.25
Price-Earnings ratio16.25
Dividend yield
Dividend yield
Average volume
1.68M
Average volume1.68M
High today
$113.01
High today$113.01
Low today
$113.01
Low today$113.01
Open price
$114.27
Open price$114.27
Volume
1.24K
Volume1.24K
52 Week high
$118.97
52 Week high$118.97
52 Week low
$67.17
52 Week low$67.17

Stock Snapshot

As of today, Incyte(INCY) shares are valued at $113.01. The company's market cap stands at 22.95B, with a P/E ratio of 16.25.

During the trading session on 2026-07-15, Incyte(INCY) shares reached a daily high of $113.01 and a low of $113.01. At a current price of $113.01, the stock is 0.0% higher than the low and still 0.0% under the high.

Trading activity shows a volume of 1.24K, compared to an average daily volume of 1.68M.

The stock's 52-week range extends from a low of $67.17 to a high of $118.97.

The stock's 52-week range extends from a low of $67.17 to a high of $118.97.

INCY News

TipRanks 1h
Incyte price target raised to $136 from $124 at BofA

BofA raised the firm’s price target on Incyte (INCY) to $136 from $124 and keeps a Buy rating on the shares. The firm will look for updated guidance on the Q2 e...

Nasdaq 16h
Incyte Now #400 Largest Company, Surpassing Weyerhaeuser

In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, Incyte Corporation (Symbol: INCY) has taken over the #4...

Incyte Now #400 Largest Company, Surpassing Weyerhaeuser
TipRanks 24h
Incyte: Early Strength in VGA039 Offsets Execution Risks; Salveen Richter Reiterates Hold and $100 Price Target

Goldman Sachs analyst Salveen Richter has maintained their neutral stance on INCY stock, giving a Hold rating yesterday. TipRanks has entered a new arena in th...

Analyst ratings

55%

of 29 ratings
Buy
41.4%
Hold
55.2%
Sell
3.4%

More INCY News

Investing.com 1d
H.C. Wainwright reiterates Incyte stock rating on VWD drug data - Investing.com

...

H.C. Wainwright reiterates Incyte stock rating on VWD drug data - Investing.com
TipRanks 1d
Incyte: VGA039 Data Reinforces Diversification Strategy as Analyst Reiterates Hold and Keeps $103 Price Target Unchanged

Analyst Judah Frommer from Morgan Stanley maintained a Hold rating on Incyte and keeping the price target at $103.00. TipRanks Welcomes a New ETF – NYSE:RANK Ti...

Benzinga 2d
Incyte Says Early Data Points To Promise For Once-Monthly Preventive Treatment For Inherited Blood Disorder

VWD is the most common inherited bleeding disorder, affecting about 1% of the population. It is caused by a deficiency or malfunction of the von Willebrand fac...

Incyte Says Early Data Points To Promise For Once-Monthly Preventive Treatment For Inherited Blood Disorder
TipRanks 2d
Incyte announces safety, efficacy data from VGA039 study

Incyte (INCY) announced complete safety and efficacy data from all patients enrolled in the Phase 1/2 multidose study of VGA039, a Protein S-targeting, investig...

People also own

Based on the portfolios of people who own INCY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.